Outset Medical, INC Form 4 insider transactions

Outset Medical's General Counsel, John L. Brottem, reported the acquisition of 9,090 shares and the sale of 32,930 shares of common stock to cover tax obligations following the vesting of performance-based restricted stock units.

Outset Medical's Chief Financial Officer, Nabeel Ahmed, reported the acquisition of 13,256 shares and the sale of 34,288 shares to cover tax obligations following the vesting of performance-based restricted stock units.

Outset Medical's CEO, Leslie Trigg, sold 33,227 shares of common stock to cover tax obligations related to the vesting of restricted stock units.

Marc Nash, SVP of Operations and R&D at Outset Medical, sold 15,011 shares of common stock to cover tax obligations related to vesting RSUs.

Outset Medical's General Counsel, John L. Brottem, sold 20,492 shares of common stock to cover tax obligations related to vesting RSUs.

Outset Medical's Chief Financial Officer, Nabeel Ahmed, sold 29,031 shares of common stock at $0.81 per share to cover tax obligations related to the vesting of restricted stock units.

Outset Medical's CEO, Leslie Trigg, sold 10,227 shares of common stock to cover tax obligations following the vesting of performance-based stock units.

An Outset Medical executive, Marc Nash, sold 720 shares of common stock to cover tax obligations related to previously vested performance stock units.

Outset Medical's General Counsel, John L. Brottem, sold 1,572 shares of common stock to cover tax obligations related to previously earned and vested performance stock units.

Outset Medical's Chief Financial Officer, Nabeel Ahmed, sold 1,835 shares of common stock to cover tax obligations related to previously earned performance stock units.

Outset Medical's CEO, Leslie Trigg, sold 5,645 shares of common stock to cover tax obligations related to vesting restricted stock units.

An Outset Medical executive, Marc Nash, sold 1,375 shares of common stock to cover tax obligations related to vesting of restricted stock units.

Outset Medical's General Counsel, John L. Brottem, sold 3,203 shares of common stock to cover tax obligations related to vesting of restricted stock units.

Outset Medical's Chief Financial Officer, Nabeel Ahmed, sold 4,221 shares of common stock to cover tax obligations related to vesting of restricted stock units.

Leslie Trigg, Chair and CEO of Outset Medical, sold shares to cover tax withholding obligations related to the vesting of restricted stock units.

Marc Nash, SVP of Operations and R&D at Outset Medical, sold 1,293 shares of common stock to cover tax withholding obligations related to vesting RSUs.

John L. Brottem, General Counsel of Outset Medical, sold 3,011 shares of common stock to cover tax withholding obligations related to vesting RSUs.

Nabeel Ahmed, CFO of Outset Medical, sold 3,971 shares of common stock to cover tax withholding obligations related to the vesting of Restricted Stock Units (RSUs).

Marc Nash, SVP of Operations and R&D at Outset Medical, sold 723 shares of common stock to cover tax withholding obligations related to vesting RSUs.

John L. Brottem, General Counsel of Outset Medical, Inc., sold 10,569 shares of common stock on June 12, 2024.

Director D. Keith Grossman exercised stock options and sold shares of Outset Medical (OM) common stock on June 3, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Director Andrea Lynn Saia acquired 25,000 shares of Outset Medical common stock on May 29, 2024, as part of a grant that vests upon the earlier of one year or the next annual meeting.

Director Brent D. Lang acquired 25,000 shares of Outset Medical, Inc. common stock on May 29, 2024, as part of a restricted stock unit (RSU) grant.

Director Dale E. Jones reports acquiring 25,000 shares of Outset Medical common stock and disposing of an unspecified amount on May 29, 2024.

Director James F. Hinrichs reports acquisition of 25,000 shares of Outset Medical, Inc. common stock on May 29, 2024.

Director Patrick Hackett acquired 25,000 shares of Outset Medical common stock on May 29, 2024, as part of a grant.

Director D. Keith Grossman acquired 25,000 shares of Outset Medical, Inc. through restricted stock units (RSUs) on May 29, 2024.

Director Karen Drexler acquired 25,000 shares of Outset Medical common stock on May 29, 2024.

Nabeel Ahmed, CFO of Outset Medical, sold 3,918 shares of common stock to cover tax withholding obligations related to vesting RSUs.

Marc Nash, SVP of Operations and R&D at Outset Medical, sold 1,097 shares of common stock to cover tax withholding obligations related to vesting RSUs.